Issuer Information

EDGAR: Contact Information
  • Name:
    Summit Therapeutics Inc.
  • Address:
    601 Brickell Key Drive
    SUITE 1000
    Miami, FLORIDA 33131
  • Phone:
    305-203-2034
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2020)
  • Previous Names:
    Summit Corp plc
    Summit Therapeutics plc

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
532728: 0001599298-24-000142
First Sale: 2024-09-11
Security Type(s): Equity
Offer Amount: $234,999,889
Amount Sold: $234,999,889
06b

CA, MD, NY, PA, TX,

523269: 0000950123-24-006261
First Sale: 2024-06-03
Security Type(s): Equity
Offer Amount: $199,999,998
Amount Sold: $199,999,998
06b

NY,

355592: 0001599298-20-000044
First Sale: 2020-11-06
Security Type(s): Equity
Offer Amount: $50,000,000
Amount Sold: $50,000,000
06b No Notices in EFD for this offering.
330048: 0001599298-20-000001
First Sale: 2019-12-24
Security Type(s): Equity
Offer Amount: $47,400,000
Amount Sold: $47,400,000
06b No Notices in EFD for this offering.
303014: 0001599298-19-000002
First Sale: 2019-01-09
Security Type(s): Equity
Offer Amount: $25,000,000
Amount Sold: $25,000,000
06b No Notices in EFD for this offering.
90826: 0001599298-14-000001
First Sale: 2014-03-04
Security Type(s): Equity
Offer Amount: $11,644,000
Amount Sold: $11,644,000
06b No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.